Publication of scientific documents as research reports and original papers has an important place in displaying the authors' knowledge, integrity, responsibility, and honesty. The same is true for the reviewers and editors. The authority of a publisher strongly depends on the qualifications of the experts who review the manuscripts, and the recommendations they provide to the authors and editors. The honesty of the authors, reviewers, and editors is of the utmost importance.
Historic Perspective of the Problem
Every scientist in chemistry and every chemistry student know that the water is H 2 O and all the molecules are of the same composition and character and have the same chemical properties. The same ideas can be applied to methanol, glucose, and millions and millions of distinct chemical substances. No one refers to water as "water and related substances". However, this was not applicable to primaquine as a description by the members of international pharmacopeia committees. The decision of pharmacopeia committees concerning primaquine was that primaquine is "primaquine and related substances" [1] [2] [3] [4] [5] [6] [7] . In this editorial, we report a profound misunderstanding in paper published by the authors Shixue G., Zhuoyu L., and Wei W. [8] , who claimed to resolve primaquine enantiomers using TLC without transforming the enantiomers to diastereomers or to a diastereomeric transitional state.
Primaquine
What meant by the "related substances" in terms of primaquine? How they related? Are the substances the degradation products produced during shelf life (storage), or are they byproducts of primaquine synthesis, remaining unreacted reagents, or something else? The members of pharmacopeia committees were diffidently silent on this issue. Primaquine phosphate [1] slowly transforms to become primaquine diphosphate [9] , and later to primaquine bis-phosphate. Primaquine has also been qualified as primaquine and its enantiomer [10] ; however, it appears to have been never straightforwardly and openly stated that primaquine has been contaminated with significant proportions of a toxic substance known as quinocide and should be classified as primaquine and quinocide. Quinocide was found in primaquine as long ago as 1997 as shown in document Figure 1 and described in publications [11] [12] [13] [14] .
Primaquine is a mixture of two enantiomers of primaquine and two enantiomers of quinocide. These enantiomers are found in raw ware primaquine; the mixture is optical active and as such is not racemic. This is shown in Figure 2 .
In primaquine, the proportions of contaminants at the time of discovery of the contaminant quinocide in (1997) (1998) were from 10% in low quality samples to 6.5% in the highest quality samples, but never less than 6%. Figure 3 is a copy of the original documents for the routine analysis of commercial raw ware primaquine. This analysis was reported by an analytical laboratory, Weifa AS, Oslo, Norway.
In this document, the total contamination level was recorded at over 8%.
The unexplained definition of "related substances" has brought to light a lot of speculations. To date, pharmacopeia committees appear to have resisted recognizing the presence of contamination of primaquine with the defined chemical and toxic substance quinocide, which exceeded accepted norms for a single known contaminant. An example of the definition given in the United States Pharmacopeia (USP) [15] is reproduced in Figure 4 .
What is the primaquine related compound A a 8-[(4-aminopentyl) amino]-6-methoxyquinoline? In what way or manner is primaquine, which is N- (6- 
How is primaquine related to 8-[(4-aminopentyl) amino]-6-methoxyquinoline as shown in Figure 5 ? The recognition of single and defined contaminant or "specified unidentified impurity" at this magnitude should lead to the demand for the requalification of the permitted amount of contamination in primaquine or acceptance of the high level of contamination with a single known contaminant in other drugs. It is not a case with the "related substance". However, according to this table from a USP publication [15] quinocide is present in primaquine at NMT 2%, despite the fact that approximately 3% of this substance was present in nearly all raw unprocessed primaquine used in the pharmaceutical industry before. Is this reduction because of the changes and use at presence new synthesis procedure for primaquine?
There are general rules for permitted amounts of a single known contaminant in pharmaceutical preparations. If these rules are followed, the pharmaceutical industry will lose significant income, which this industry receives by launching improper products (with single contaminant about 2%) as primaquine with the apparent blessings of pharmacopeia committees.
Knowledge of the contamination of primaquine with quinocide has been available since 1997. We had many problems to overcome before we could break barriers to present this information in 2003 [11] . The pharmaceutical industry and pharmacopeia committees put obstacles in the way of obtaining this information. Globally, the pharmaceutical industry, pharmaceutical authorities, and pharmacopeia committees conducted a circus performance, the circus of "non-recognition the fact of contamination of primaquine with quinocide". The Chongqing Institute for Drug Control was no exception to the rule [8] . At present, other circus performances are taking place: "the non-information about the toxic abilities of the mixture of 8-[(4-aminopentyl)amino]-6-methoxyquinoline with primaquine."
Isomers and Isomerism
In organic chemistry, there are several million different compounds, but most of them are composed of very few elements: C, H, O, N, S, halides, and more rarely, several metals. A chemical formula presents the substance by composition of these elements qualitatively and quantitatively, for example: C 4 H 10 . The formula, or as it is called, the empirical formula for this substance can represent n-butane. However, two different substances with this empirical formula exist, (normal) n-butane and 2-methylpropane. In isomers, the elements are commonly found in the same number in chemical formulae, but are connected in various different ways. The carbon atoms in each of these substances are connected to each other in a different way. The connection of carbon atoms in a molecule is shown by the structural formula. The structural formulae of both n-butane and 2-methylpropane are shown in Figure 6 .
Different compounds that have the same empirical, molecular formula are "empirical formula isomers". Two empirical formula isomers can also be the constitutional isomers. Primaquine and quinocide are shown in Figure  7 . They are also empirical formula and constitutional isomers at the same time.
Constitutional isomers are isomers that differ in the order in which their atoms are connected, and are also known as "structural isomers". The formal definition of constitutional isomers is "compounds that have the same molecular formula and different connectivity".
Because carbon atoms have a valence of four, they can be connected to four other different atoms. Valences can be visually placed at the corners of a tetrahedron; such constructions are symmetric if all corners of the tetrahedron are occupied by atoms of the same type and can be superimposed or asymmetric if the four corners are occupied by different atoms and cannot be superimposed, as shown in Figure 8 . This is also true if the atoms are changed to functional groups or other substituents. The carbon in molecules in Figure 8 is known as an asymmetric or chiral carbon. Solutions of molecules containing a chiral carbon in their structure have the property of being able to rotate the plane of polarized light. Two molecules with different spatial locations of different atoms around carbon are stereoisomers. Enantiomers are two stereoisomers that are related to each other by a mirror reflection: they are mirror images of each other, which are non-superimposable. Two enantiomers are shown in Figure 8 . Figure 8 , by contrast with isomers in Figure 7 , have the same physicochemical properties such as melting point, boiling point, and solubility, with the exception of rotating a plane of polarized light in opposite directions. If, when in solution, all molecules of the enantiomer rotate the plane of polarized light in a clockwise direction they are described as the (+)-enantiomer. If, when in solution all molecules of the enantiomer rotate the plane of polarized light in a counterclockwise direction they are described as the (-)-enantiomer. The angle of the rotation of a plane of polarized light by each molecule of an enantiomer pair has the same magnitude, but different direction. The enantiomers crystalize as right or left crystals depending on the sign of the enantiomer. Enantiomer molecules of different signs of rotation have different reactivity toward enzymes and biological systems.
Enantiomers in

Diastereomers
There are a number of other isomers; however, it is of interest here to understand that diastereomers are isomers with two chiral carbons in their molecules as shown in Figure 9 .
Two diastereomers respectively, have different physicochemical properties such as melting point, boiling point, and solubility. They are also can be optically active; a solution of diastereomers can rotate a plane of polarized light.
Mixture of Enantiomers
In nature, because of stereospecific synthesis involving enzymes, as a rule all molecules that are formed by primary synthesis have a common stereochemistry. In biology, adopted nomenclature for the chiral carbons is levo (L-) and dextro (D-). All naturally occurring amino acids in proteins belong to the L-stereo chemical series. It is possible to find amino acids with D-chirality; however, this is because of secondary metabolic transformation. "Enantiomer" is the modern term for "optical isomer." In industrial synthesis, stereospecific synthesis is seldom used. It is usual to use nonstereospecific synthesis. Therefore, industrial synthesis usually results in a mixture of enantiomers. A solution of 50% (+)-enantiomers and 50% of (-)-enantiomers does not rotate plane polarized light. The solution is called optically inactive or racemic, or a simple "racemate". A solution in which one of the enantiomer presented in excess, but not to the exclusion of the other, is called "enantioenriched".
However, the (+)/(-) system has no fixed relationship with the (R)/(S) system. Optical activity is easy to measure, but advanced equipment is needed to decide whether a molecule has an R or S configuration. Pharmacopeia committees broadly and heavily misuse this point.
Enantiomer Resolution (Chiral Resolution)
Several different techniques are used to separate substances. One of the techniques is chromatography. The separation of enantiomers by chromatography is called "resolution of enantiomers" or "chiral resolution", or simply "resolution". The chromatography technique is mainly based on the physicochemical properties of molecules.
Open Access IJAMSC Isomers that have distinct differences in melting point, boiling point, or solubility can be separated by chromatographic methods. However, enantiomers have the same physicochemical properties and cannot be separated by traditional chromatography. Nevertheless, chromatogra- phic separation or so-called resolution can be performed by chromatography for enantiomers. Chromatography resolution of enantiomers is based on the fact that diastereomers have different physicochemical properties such as melting point, boiling point, or solubility. Three main approaches are used. 1) A synthetic reaction of a I. BRONDZ 87 mixture of a pair of enantiomers with an optically active isomer. The demands of the reaction are that the products become diastereomers and that diastereomers can be decomposed to the initial enantiomers and an additional product (optically active substance). 2) The enantiomers and an optically active substance in solution (mobile phase) compose a transitional diastereomeric state and this transitional state is easy decomposed into initial reagents. The specific substance in the mobile phase, which is called a "chiral selector", is an optically active substance.
3) The use of an "enantio-/chiral support" or "enantio-/chiral stationary phase"; which, under chromatographic conditions, forms a transitional diastereomeric state with enantiomers. The transitional diastereomeric state is in mass balance with the reactants. The reactants (enantiomer stationary phase/enantiomers in solution) will be composed and decomposed during the chromatographic process. In all of these approaches, the transformation of a mixture of a pair of enantiomers to the mixture of diastereomers is needed for resolution. An enantiomer mixture without these processes cannot be resolved.
Is It "A New Method to Resolve
Enantiomers on TLC" without Transforming the Enantiomers to Diastereomers or to a Diastereomeric Transitional State?
The publication by Shixue et al. [8] , (the part of text presented in Figure 10 ) describes a groundbreaking discovery, which can be summarized as separation of sub- Open Access IJAMSC I. BRONDZ 88 stances related to primaquine and its enantiomer that was achieved by using TLC and HPLC with mobile phases, without selectors, and on a silica based support/stationary phase (achiral phase). Most interesting in this discovery was the authentication of a spot as an enantiomer to primaquine. The spot was separated from primaquine and was above the primaquine spot on the TLC plate. The spot was presented as an authentic enantiomer of primaquine.
Without a doubt, the results of this outstanding discovery were directly inspired by publication of information in pharmacopoeias [6, 7, 9] and in the other outstanding scientific publications of authoritative power. How could a simple pharmaceutical analyst stand against the "Bibles of Pharmacy?" The qualifications of the leading scientists in the Chongqing Institute of Drug Control Committee, Chongqing, 400015, China who recognized and allowed publication of these results are not clear. However, of most interest is in the absence of reactions from the reviewers and editor of China Pharmaceuticals. How could this paper be published in a serious journal?
My personal opinion is that members of pharmacopoeia committees have guarded the pharmaceutical industry by concealing knowledge about the presence of other substance such as quinocide as a contaminant in primaquine by presenting the contaminant as related substance or as enantiomer.
An interesting approach was taken in the USP [16] in which description of related substances or (S) and (R) enantiomers is omitted. Who would protest against the definition that primaquine is a (+/-)-8-[(4-amino-1-methylbutyl)amino]-6-methoxyquinoline with an empirical formula C 15 H 21 N 3 O as it defined in [16] . The analysis of primaquine was published [11] [12] [13] [14] [17] [18] [19] [20] [21] and as a technical note in 2006 in [17] , and discussion is in progress [14, [18] [19] [20] [21] .
Conclusions
1) Plagiarism, falsification [22] , and corruption by some authors, journal editors, and reviewers, are the most important plague of scientific and professional publication [23] .
2) This defect is present in all classes of publications including the highly indexed and those with high reputations.
3) A harder line should be taken against plagiarism.
4) The identity of reviewers should be known.
5) The introduction of academic editors for the review of papers is needed.
6) The exclusion of Editors-in-Chief found to have concealed falsified papers should be taken as an action by all publishers.
7) The exclusion of Editors-in-Chief guilty of corruption should be taken as an action by all publishers.
